The RealReal, Inc.
REAL · NASDAQ
Analyst ratings
buy · 6 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| June 3, 2026 | BTIG | Reiterates | Buy | $17.00 |
| May 8, 2026 | UBS | Maintains | Neutral | $14.00 |
| May 8, 2026 | BTIG | Maintains | Buy | $17.00 |
| February 27, 2026 | Baird | Maintains | Neutral | $16.00 |
| February 27, 2026 | BTIG | Reiterates | Buy | $18.00 |
| January 22, 2026 | Keybanc | Maintains | Overweight | $20.00 |
| January 8, 2026 | UBS | Maintains | Neutral | $16.00 |
| December 30, 2025 | BTIG | Maintains | Buy | $18.00 |
| December 16, 2025 | Wells Fargo | Maintains | Overweight | $20.00 |
| December 12, 2025 | B. Riley Securities | Maintains | Buy | $17.00 |
| November 11, 2025 | UBS | Maintains | Neutral | $14.00 |
| November 11, 2025 | B. Riley Securities | Reiterates | Buy | $14.00 |
| November 11, 2025 | Baird | Maintains | Neutral | $13.00 |
| November 11, 2025 | BTIG | Maintains | Buy | $15.00 |
| October 15, 2025 | UBS | Maintains | Neutral | $10.50 |
| September 15, 2025 | B. Riley Securities | Maintains | Buy | $12.00 |
| September 10, 2025 | BTIG | Maintains | Buy | $11.00 |
Path to profitability and earnings trajectory
Analysts estimate a meaningful earnings improvement of $0.21 per share this year and an additional $0.16 per share increase next year. The RealReal has also demonstrated the ability to beat consensus estimates significantly, as seen when it reported -$0.09 versus an expected -$0.21 per share — a 57.14% positive surprise.
The RealReal continues to post negative earnings, missing consensus estimates in recent quarters with a -7.69% earnings surprise. Analysts project further per-share losses in the near term, and the company's stock score of 34/100 — well below the 50 threshold associated with market outperformance — signals deep uncertainty about sustainable profitability.
Stock valuation and price target divergence
Wall Street's analyst consensus rates REAL a Buy, with an average 12-month price target of $17.25 — representing a potential upside of nearly 54% from its last close of $11.21. UBS, despite trimming its target to $14, maintained a Neutral rating, reflecting a floor of institutional confidence in the company's valuation.
Quantitative models and technical scoring paint a starkly different picture, rating REAL a Sell with a score of 34/100. Short-term forecasts project the stock declining significantly from current levels, and the share price trading below its 200-day simple moving average of $12.06 reinforces concerns that the stock may be overvalued at current levels.
Technical momentum versus longer-term trend deterioration
REAL's share price sits above its 5, 20, and 50-day exponential moving averages, with MACD and RSI indicators both generating Buy signals. The stock has risen 19.44% over the past two weeks, and key moving average crossovers suggest short- to medium-term momentum remains constructive for the stock.
Despite recent short-term gains, REAL remains entrenched in a wide, falling long-term trend. The stock is overbought on RSI14 and sits near trend resistance, making a near-term correction highly probable. A 3-month price decline of nearly 10% is projected, with a 90% probability the stock lands between $4.07 and $6.01 by quarter's end.